Newsletters

Stay up-to-date with the latest news and articles written by our team of experts to assist medical device companies in navigating trends and challenges in regulatory affairs, quality management systems and clinical affairs.

Subscribe To AlvaMed's Newsletter

A monthly analysis of the medical device industry, quality and regulatory developments, and other useful information for industry professionals. (Contact details are never shared outside our organization.)

Clinical Evaluations and the EU Market

Clinical evaluation is arguably one of the most important topics in the international medical device

FDA Third Party Review Programs

In August 1996, the FDA launched what was known as the Voluntary Third Party 510(k)

The MHRA Roadmap: Navigating the UK Market

While the European Union (EU) remains hard at work in developing its new regulatory framework

FDA Announces the Issuance of Final Rule Amending the Quality System Regulation

Today, the resounding echo of the starting gun reverberates globally, signaling the commencement of a

EU Commission proposes another extension for IVDR transition

On January 23rd, amid concerns that there is not enough time for manufacturers to comply

FDA ESTABLISHES A NEW DIGITAL HEALTH ADVISORY COMMITTEE

The world of technology is moving at lighting speed. We are experiencing advances in software

FDA UPDATE: FINAL GUIDANCE SUBMISSION AND REVIEW OF STERILITY INFORMATION IN PREMARKET NOTIFICATION (510(K)) SUBMISSIONS FOR DEVICES LABELED AS STERILE

On Jan. 8, 2024, the FDA updated the final guidance on “Submission and Review of

MDCG UPDATES Q&A ON IMPORTERS AND DISTRIBUTORS

The Medical Device Coordination Group (MDCG), the regulatory body that works toward ensuring the safe

Decentralized Clinical Trials: A Clinical Trial Optimization Opportunity

Recent trends in clinical studies, including the nearly ubiquitous move to electronic data capture (EDC)